You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

brain metastases;bevacizumab;utidelone

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Sep 15, 2022

Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)

Recruiting
  • Breast Cancer With Brain Metastases
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023

NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage II
  • +3 more
  • Serplulimab combined with bevacizumab and first-line chemotherapy
  • Guangzhou, Guangdong, China
    Likun Chen
Apr 10, 2023

Mammary Tumors, Human Trial in Tianjin (eutidrone etoposide bevacizumab)

Recruiting
  • Mammary Neoplasms, Human
  • eutidrone etoposide bevacizumab
  • Tianjin, Tianjin, China
    Yehui Shi
Mar 10, 2023

Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • (no location specified)
Apr 2, 2023

NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Brain Neoplasms
  • (no location specified)
Dec 9, 2022

Non-squamous NSCLC Trial in Guangzhou (FSRT combined with Bevacizumab)

Active, not recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • FSRT combined with Bevacizumab
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Mar 13, 2023

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +2 more
  • Los Angeles, California
  • +17 more
Jan 27, 2023

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Melanoma, NSCLC, Brain Metastasis Trial in New Haven, Tampa (Pembrolizumab plus Bevacizumab)

Recruiting
  • Melanoma
  • +2 more
  • Pembrolizumab plus Bevacizumab
  • New Haven, Connecticut
  • +1 more
Feb 18, 2022

Breast Cancer, Brain Metastases Trial in Taiwan (BEEP regimen)

Active, not recruiting
  • Breast Cancer
  • Brain Metastases
  • BEEP regimen
  • Kaohsiung, Taiwan
  • +7 more
May 6, 2021

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023

Brain Metastases, Radionecrosis, Pulmonary Cancer Trial in Paris (MRI with CEST sequence, IVIM and ASL sequence)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • MRI with CEST sequence, IVIM and ASL sequence
  • Paris, France
    Hôpital Bichat-Claude Bernard
Aug 3, 2023

NSCLC Trial in Tai'an (Ametinib combined with bevacizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Ametinib combined with bevacizumab
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Feb 22, 2023

Brain Metastases, Non Small Cell Lung Cancer, Sintilimab Trial in Guangzhou (sintilimab)

Unknown status
  • Brain Metastases
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of Cancer Center
Dec 25, 2019

Breast Cancer Trial (Pyrotinib, Temozolomide Injection, SHR-1316)

Unknown status
  • Breast Cancer
  • (no location specified)
Mar 9, 2020

Radionecrosis, Brain Metastases Trial in Canada, United States (bevacizumab, corticosteroids, )

Terminated
Has Results
  • Radionecrosis
  • Brain Metastases
  • Anchorage, Alaska
  • +340 more
Jul 15, 2021

HER-2 Negative Breast Cancer Trial (Utidelone Combined with Bevacizumab)

Not yet recruiting
  • HER-2 Negative Breast Cancer
  • Utidelone Combined with Bevacizumab
  • (no location specified)
May 26, 2022

Advanced Solid Tumor Trial (Utidelone Capsule (Part 1), Drug A Utidelone Capsule (Part 2: Group A-B), Drug A Utidelone Capsule

Not yet recruiting
  • Advanced Solid Tumor
  • Utidelone Capsule (Part 1)
  • +4 more
  • (no location specified)
Jan 16, 2023

Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

Recruiting
  • Lung Cancer
  • Olaparib+Bevacizumab to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
  • +3 more
Nov 9, 2022

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

Pancreatic Tumors Trial in Shanghai (Utidelone injection in combination with gemcitabine)

Recruiting
  • Pancreatic Neoplasms
  • Utidelone injection in combination with gemcitabine
  • Shanghai, Shanghai, China
    Shanghai First People's Hospital
Mar 21, 2023

Tumors Metastatic to Brain, Unspecified Adult Solid Tumor Trial in Cleveland (stereotactic radiosurgery, quality-of-life

Suspended
  • Tumors Metastatic to Brain
  • Unspecified Adult Solid Tumor
  • stereotactic radiosurgery
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 4, 2022